“In a federal antitrust complaint, pharmacies that buy drugs from Pfizer and Wyeth say their proposed $68 billion merger would give the new company control of 40 percent of the market, cost thousands of jobs and lead to lower quality drugs at higher prices.”
Article:
Like this:
Like Loading...
Related
Tags: antitrust, Pfizer, Wyeth
This entry was posted on August 24, 2009 at 2:14 pm and is filed under Company News, Lawsuits. You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
Leave a Reply